Site Selection

Level 1

  • 1

    Module 1: Site Capabilities Assessment

    • Slide 38

    • Slide 39

    • Slide40

    • Slide 41

    • Slide 42

    • slide43

    • Slide 44

    • Slide45

    • Slide 46
  • 2

    Module 2: Therapeutic Areas

    • slide 47

    • Slide48

    • slide 49

    • slide 50

    • slide 51

    • slide 52

    • slide 53

    • slide 54

    • Slide_55

    • slide 56

    • slide 57

    • slide 58

    • slide 59

    • slide 60

    • slide 61

    • slide 62

    • slide 63

    • slide 64

    • slide 65

    • slide 66

    • slide 67

    • slide 68

    • slide 69

    • slide 70

    • Slide_71

    • slide 72

    • slide 73

    • slide 74

    • slide 75

    • slide 76b

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.